Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kcentra for Apixaban Reversal in Healthy Volunteers
NCT02270918Phase 1Completed
- Sponsor
- Thomas Jefferson University
- Start
- Nov 2014
- Primary completion
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in hemorrhage comparing Apixaban with Kcentra with Apixaban with placebo (2 arms). Primary endpoint: Thrombin Generation Assay at 30 minutes. Started Nov 2014; status: completed.
02
Drugs
coagulation factor X human
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT02270918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02270918.